325 related articles for article (PubMed ID: 31692008)
1. The CCL20 and CCR6 axis in psoriasis.
Furue K; Ito T; Tsuji G; Nakahara T; Furue M
Scand J Immunol; 2020 Mar; 91(3):e12846. PubMed ID: 31692008
[TBL] [Abstract][Full Text] [Related]
2. Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment.
Kim TG; Byamba D; Wu WH; Lee MG
Exp Dermatol; 2011 Oct; 20(10):855-7. PubMed ID: 21824198
[TBL] [Abstract][Full Text] [Related]
3. Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.
Getschman AE; Imai Y; Larsen O; Peterson FC; Wu X; Rosenkilde MM; Hwang ST; Volkman BF
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12460-12465. PubMed ID: 29109267
[TBL] [Abstract][Full Text] [Related]
4. Development of psoriasis by continuous neutrophil infiltration into the epidermis.
Katayama H
Exp Dermatol; 2018 Oct; 27(10):1084-1091. PubMed ID: 30019426
[TBL] [Abstract][Full Text] [Related]
5. CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues.
Zhang W; Nie L; Wang Y; Wang XP; Zhao H; Dongol S; Maharjan S; Cheng L
PLoS One; 2013; 8(6):e66286. PubMed ID: 23823618
[TBL] [Abstract][Full Text] [Related]
6. Anti-psoriasis effect of 18β-glycyrrhetinic acid by breaking CCL20/CCR6 axis through its vital active group targeting GUSB/ATF2 signaling.
Wei J; Zhang J; Hu F; Zhang W; Wu Y; Liu B; Lu Y; Li L; Han L; Lu C
Phytomedicine; 2024 Jun; 128():155524. PubMed ID: 38552435
[TBL] [Abstract][Full Text] [Related]
7. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.
Harper EG; Guo C; Rizzo H; Lillis JV; Kurtz SE; Skorcheva I; Purdy D; Fitch E; Iordanov M; Blauvelt A
J Invest Dermatol; 2009 Sep; 129(9):2175-83. PubMed ID: 19295614
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17A and Keratinocytes in Psoriasis.
Furue M; Furue K; Tsuji G; Nakahara T
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070069
[TBL] [Abstract][Full Text] [Related]
9. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
10. The EGFR-ERK/JNK-CCL20 Pathway in Scratched Keratinocytes May Underpin Koebnerization in Psoriasis Patients.
Furue K; Ito T; Tanaka Y; Hashimoto-Hachiya A; Takemura M; Murata M; Kido-Nakahara M; Tsuji G; Nakahara T; Furue M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936670
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
[TBL] [Abstract][Full Text] [Related]
12. Indirubin attenuates IL-17A-induced CCL20 expression and production in keratinocytes through repressing TAK1 signaling pathway.
Zhao J; Xie X; Di T; Liu Y; Qi C; Chen Z; Li P; Wang Y
Int Immunopharmacol; 2021 May; 94():107229. PubMed ID: 33611057
[TBL] [Abstract][Full Text] [Related]
13. The relationship between CCR6 and its binding partners: does the CCR6-CCL20 axis have to be extended?
Lee AY; Phan TK; Hulett MD; Körner H
Cytokine; 2015 Mar; 72(1):97-101. PubMed ID: 25585877
[TBL] [Abstract][Full Text] [Related]
14. CCR6 as a possible therapeutic target in psoriasis.
Hedrick MN; Lonsdorf AS; Hwang ST; Farber JM
Expert Opin Ther Targets; 2010 Sep; 14(9):911-22. PubMed ID: 20629596
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells.
Hirata T; Osuga Y; Takamura M; Kodama A; Hirota Y; Koga K; Yoshino O; Harada M; Takemura Y; Yano T; Taketani Y
Endocrinology; 2010 Nov; 151(11):5468-76. PubMed ID: 20881253
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.
Homey B; Dieu-Nosjean MC; Wiesenborn A; Massacrier C; Pin JJ; Oldham E; Catron D; Buchanan ME; Müller A; deWaal Malefyt R; Deng G; Orozco R; Ruzicka T; Lehmann P; Lebecque S; Caux C; Zlotnik A
J Immunol; 2000 Jun; 164(12):6621-32. PubMed ID: 10843722
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptors in the pathogenesis and therapy of psoriasis.
Mabuchi T; Chang TW; Quinter S; Hwang ST
J Dermatol Sci; 2012 Jan; 65(1):4-11. PubMed ID: 22177422
[TBL] [Abstract][Full Text] [Related]
18. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.
Hirota K; Yoshitomi H; Hashimoto M; Maeda S; Teradaira S; Sugimoto N; Yamaguchi T; Nomura T; Ito H; Nakamura T; Sakaguchi N; Sakaguchi S
J Exp Med; 2007 Nov; 204(12):2803-12. PubMed ID: 18025126
[TBL] [Abstract][Full Text] [Related]
19. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
[TBL] [Abstract][Full Text] [Related]
20. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.
Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]